Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the efficacy and the safety of insulin glulisine in type I Diabetes Melittus (DM)
patients
Secondary Objective:
To evaluate the insulin glulisine doses To assess the patient satisfaction